Literature DB >> 9811686

Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.

B Degrève1, M Johansson, E De Clercq, A Karlsson, J Balzarini.   

Abstract

The thymidine kinases (TKs) of herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV) were expressed in human osteosarcoma cells as fusion proteins with the green fluorescent protein (GFP), and their intracellular localizations were determined. The three TK-GFP fusion products were localized in different subcellular compartments of the transfected tumor cells. HSV-1 TK-GFP was localized exclusively in the nucleus, HSV-2 TK-GFP was predominantly found in the cytosol, while VZV TK-GFP was localized in both the nucleus and the cytosol. In support of these findings, we identified a nuclear localization signal (NLS) in the N-terminal arginine-rich region of HSV-1 TK that was absent in HSV-2 and VZV TK. The first 34 amino acids proved necessary for the specific nuclear localization of HSV-1 TK and, when added to the VZV TK-GFP gene construct, also sufficed to specifically target VZV TK-GFP to the nucleus. Further analysis of this NLS through site-directed mutagenesis revealed that the basic amino acid-rich nonapeptide 25R-R-T-A-L-R-P-R-R33 is of crucial importance in the nuclear targeting of HSV-1 TK. In particular, we revealed that the presence of the arginine residues at positions 25, 26, 30, 32, and 33 is obligatory for efficient NLS functioning, whereas arginine and histidine residues outside of the nonapeptide (i.e., residues R18, R20, and H22) did not change the functional properties of the NLS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811686      PMCID: PMC110456     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Evidence that deletion of coding sequences in the 5' end of the thymidine kinase gene of herpes simplex virus type 1 affects the stability of the gene products.

Authors:  L Haarr; T Flatmark
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

2.  Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.

Authors:  J Balzarini; E De Clercq; A Verbruggen; D Ayusawa; K Shimizu; T Seno
Journal:  Mol Pharmacol       Date:  1987-09       Impact factor: 4.436

3.  The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.

Authors:  S Efstathiou; S Kemp; G Darby; A C Minson
Journal:  J Gen Virol       Date:  1989-04       Impact factor: 3.891

4.  The effect of protein context on nuclear location signal function.

Authors:  B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

5.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus type I and type II. II. Purification and characterization.

Authors:  Y C Cheng; M Ostrander
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

7.  Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus.

Authors:  K Shiraki; T Ogino; K Yamanishi; M Takahashi
Journal:  J Gen Virol       Date:  1985-02       Impact factor: 3.891

8.  Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

Authors:  J Balzarini; E de Clercq; D Ayusawa; T Seno
Journal:  FEBS Lett       Date:  1985-06-03       Impact factor: 4.124

9.  Transfection with the isolated herpes simplex virus thymidine kinase genes. I. Minimal size of the active fragments from HSV-1 and HSV-2.

Authors:  G R Reyes; K T Jeang; G S Hayward
Journal:  J Gen Virol       Date:  1982-10       Impact factor: 3.891

10.  Synthetic peptides as nuclear localization signals.

Authors:  D S Goldfarb; J Gariépy; G Schoolnik; R D Kornberg
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

View more
  15 in total

1.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Authors:  Michael B Gill; Jeffery L Kutok; Joyce D Fingeroth
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

3.  Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.

Authors:  L Naesens; L Lenaerts; G Andrei; R Snoeck; D Van Beers; Antonin Holy; Jan Balzarini; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction.

Authors:  Michael B Gill; Rachel Turner; Philip G Stevenson; Michael Way
Journal:  EMBO J       Date:  2014-12-03       Impact factor: 11.598

5.  Characterization of the subcellular localization of herpes simplex virus type 1 proteins in living cells.

Authors:  Junji Xing; Shuai Wang; You Li; Hong Guo; Lei Zhao; Weiwei Pan; Fusen Lin; Huifang Zhu; Lei Wang; Meili Li; Lin Wang; Chunfu Zheng
Journal:  Med Microbiol Immunol       Date:  2010-10-15       Impact factor: 3.402

6.  Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.

Authors:  Vladimir Ponomarev; Michael Doubrovin; Inna Serganova; Tatiana Beresten; Jelena Vider; Aleksander Shavrin; Ludmila Ageyeva; Julius Balatoni; Ronald Blasberg; Juri Gelovani Tjuvajev
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

7.  Imaging tri-fusion multimodality reporter gene expression in living subjects.

Authors:  Pritha Ray; Abhijit De; Jung-Jun Min; Roger Y Tsien; Sanjiv S Gambhir
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

8.  Suicide Gene Therapy for Cancer - Current Strategies.

Authors:  Paul Zarogoulidis; Kaid Darwiche; Antonios Sakkas; Lonny Yarmus; Haidong Huang; Qiang Li; Lutz Freitag; Konstantinos Zarogoulidis; Marek Malecki
Journal:  J Genet Syndr Gene Ther       Date:  2013-08-09

9.  ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers.

Authors:  Evan K Day; Anne Campbell; Ashley Pandolf; Troy Rogerson; Qing Zhong; Aizhen Xiao; Benjamin Purow; Matthew J Lazzara
Journal:  Mol Ther       Date:  2020-12-15       Impact factor: 11.454

10.  A transgenic tri-modality reporter mouse.

Authors:  Xinrui Yan; Pritha Ray; Ramasamy Paulmurugan; Ricky Tong; Yongquan Gong; Ataya Sathirachinda; Joseph C Wu; Sanjiv S Gambhir
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.